Interaction of Gene Variants Dictates Parkinson’s Risk, Study Finds
Scientists have discovered that the individual contribution of gene variants known to increase the risk of Parkinson’s disease can…
Articles by Joana Carvalho, PhD
Dopamine-Resistant Tremors Caused by Abnormal Brain Activity, Study Finds
Parkinson’s patients whose tremors respond poorly to dopaminergic medications are likely experiencing abnormal brain activity outside the brain’s…
High Corticosterone Levels a Risk Factor for Parkinson’s, Mouse Study Finds
High levels of corticosterone — a hormone that regulates energy, immune, and stress responses — is a risk factor…
IL-17A Accelerates Brain Inflammation and Degeneration in Animal Models of Parkinson’s, Study Finds
Interleukin-17A (IL-17A) — a molecule that is involved in immune and inflammatory responses — accelerates brain inflammation and degeneration in…
Microbes in Saliva May Offer Way of Detecting and Understanding Early Stages of Parkinson’s, Study Says
A saliva test to detect oral microbes may offer an accurate way of detecting Parkinson’s in its early stages and…
MS Medicine Copaxone May Have Benefits in Parkinson’s Disease, Mouse Study Finds
Treatment with Copaxone (glatiramer acetate), an FDA-approved medicine for multiple sclerosis, can restore motor function and biochemical…
Midbrain Area Measurements Can Be Used to Distinguish Parkinson’s From PSP, Study Says
Midbrain area measurements can be used to distinguish patients with Parkinson’s disease from those with progressive supranuclear palsy,…
Gut Alpha-Synuclein May Be Used as Biomarker of Parkinson’s, Study Suggests
Alpha-synuclein levels in the gut are linked to Parkinson’s disease, indicating that gut alpha-synuclein may be used in…
Aptinyx to Launch Phase 2 Study of NYX-458 to Treat Cognitive Impairment
Positive preclinical and Phase 1 clinical data support further assessment of Aptinyx‘s investigational compound NYX-458Â for the treatment of…
Abbott Partners with NIH on BRAIN Initiative to Use Neuromodulation Technologies
Abbott is partnering with the National Institutes of Health (NIH) to explore the use of its neuromodulation…